1. Home
  2. CSL vs PEN Comparison

CSL vs PEN Comparison

Compare CSL & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

HOLD

Current Price

$402.66

Market Cap

17.1B

Sector

Industrials

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$340.67

Market Cap

14.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSL
PEN
Founded
1917
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1B
14.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CSL
PEN
Price
$402.66
$340.67
Analyst Decision
Buy
Buy
Analyst Count
6
18
Target Price
$386.67
$350.94
AVG Volume (30 Days)
550.0K
1.4M
Earning Date
02-03-2026
02-23-2026
Dividend Yield
1.08%
N/A
EPS Growth
N/A
367.34
EPS
17.12
4.14
Revenue
$5,019,900,000.00
$1,333,798,000.00
Revenue This Year
$2.85
$17.03
Revenue Next Year
$4.34
$14.38
P/E Ratio
$23.89
$81.99
Revenue Growth
0.33
14.61
52 Week Low
$293.43
$221.26
52 Week High
$435.92
$362.41

Technical Indicators

Market Signals
Indicator
CSL
PEN
Relative Strength Index (RSI) 66.23 51.84
Support Level $397.47 $337.63
Resistance Level $432.91 $340.92
Average True Range (ATR) 13.40 3.47
MACD 3.25 -3.12
Stochastic Oscillator 69.03 12.85

Price Performance

Historical Comparison
CSL
PEN

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: